Literature DB >> 23820280

Mitral regurgitation and axial flow left ventricular assist device: a computer simulation study.

Matija Jelenc1, Blaž Jelenc, Bojan Vrtovec, Ivan Kneževič.   

Abstract

Good right ventricular function is one of the major determinants of long-term outcomes in patients with implanted left ventricular assist devices (LVADs). In the present study, a computer model was developed to assess the impact of mitral regurgitation on right ventricular workload at different levels of LVAD support. Left ventricular assist device was simulated by a model of HeartMate II. The computer model has shown that the regurgitant volume of the mitral valve falls significantly only after the systolic pressure in the left ventricle decreases, which occurs at higher LVAD revolutions per minute (RPM) when there is no ejection through the aortic valve. However, at low LVAD RPM, the pressures in the left atrium and the pulmonary artery decrease significantly, despite a small decrease in regurgitant volume. According to the computer model, LVAD support decreases mitral regurgitation. Furthermore, regurgitant volume has a smaller impact on the right ventricular afterload when compared with a heart without LVAD support.

Entities:  

Mesh:

Year:  2013        PMID: 23820280     DOI: 10.1097/MAT.0b013e31829ff57d

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  2 in total

1.  Impact of mitral valve intervention with left ventricular assist device implantation on postoperative outcomes and morphologic change.

Authors:  Hiroki Hata; Tomoyuki Fujita; Hatsue Ishibashi-Ueda; Kensuke Kuroda; Osamu Seguchi; Yorihiko Matsumoto; Masanobu Yanase; Takuma Sato; Seiko Nakajima; Norihide Fukushima; Junjiro Kobayashi
Journal:  J Artif Organs       Date:  2017-11-27       Impact factor: 1.731

2.  Mathematical modeling of cardiac function to evaluate clinical cases in adults and children.

Authors:  Selim Bozkurt
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.